Wise v. Bayer

281 F. Supp. 2d 878, 2003 U.S. Dist. LEXIS 15919, 2003 WL 22119188
CourtDistrict Court, W.D. Louisiana
DecidedAugust 8, 2003
DocketCIV.A. 03-1095-A
StatusPublished

This text of 281 F. Supp. 2d 878 (Wise v. Bayer) is published on Counsel Stack Legal Research, covering District Court, W.D. Louisiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wise v. Bayer, 281 F. Supp. 2d 878, 2003 U.S. Dist. LEXIS 15919, 2003 WL 22119188 (W.D. La. 2003).

Opinion

RULING

DRELL, District Judge.

Before the Court are the Motion to Remand filed by Plaintiff, John Richard Wise, on June 30, 2003, 1 and the Motion to Stay, filed July 15, 2003 by Defendants, Bayer Corporation (hereinafter sometimes referred to as “Bayer”) and SmithKline Beecham Corporation d/b/a GlaxoSmithK-line (hereinafter sometimes referred to as “GSK”). 2 Although Defendants have not *879 filed a document titled “opposition” to the Motion to Remand, their objections to that Motion are set forth in the Notice of Removal filed on June 9, 2003 and in the brief supporting the Motion to Stay. 3 The Court finds there is no need for oral argument. For the reasons that follow, Plaintiffs Motion to Remand is GRANTED, and Defendants’ Motion to Stay is DENIED.

BACKGROUND

Mr. Wise, a Louisiana citizen, filed his Original Petition in the 8th Judicial District Court for the Parish of Winn, Louisiana on March 20, 2003. 4 Plaintiff named Bayer, A.G.; Bayer Corporation; Bayer Pharmaceutical Division — North America; GlaxoSmithKline, PLC; and SmithKline Beecham Corporation as defendants. It is undisputed that all the defendants named in the Original Petition are citizens of states other than Louisiana. 5 Thus, within the four walls of the Original Petition, complete diversity exists as contemplated by 28 U.S.C. § 1332.

Plaintiff alleges he took the drug Baycol from September 2000 through August 2001. Mr. Wise contends he discovered in December 2002 that his claimed medical problems were potentially related to his use of Baycol. He further asserts that Defendants “manufactured, marketed, distributed, and/or placed into the stream of commerce” 6 the drug Baycol, which drug was allegedly defectively designed or formulated. Mr. Wise also sets forth claims for failing to warn Plaintiff and/or his physicians of the supposed dangers associated with Baycol, for negligence, and for intentionally and/or negligently misrepresenting information about the drug.

Bayer Corporation was served with Plaintiffs Original Petition on April 11, 2003. 7 SmithKline Beecham Corporation d/b/a GlaxoSmithKline filed an Answer to the Original Petition in state court on April 21, 2003. 8

On May 7, 2003, Mr. Wise submitted a First Amending Petition to the state court, in which document he seeks to add Louisiana State University Health Sciences Center (hereinafter sometimes referred to as “LSUHSC”), a Louisiana health care provider, as a defendant. Plaintiff also asks to amend the Original Petition to add a listed injury and to aver the amount of damages being sought is greater than $50,000. 9 Bayer Corporation received a copy of the First Amending Petition on May 8, 2003. 10

Bayer Corporation filed its Answer to Plaintiffs Original Petition in state court on May 22, 2003. 11 Subsequently, on June 9, 2003, Bayer and GSK filed a Notice of Removal to this Court. 12

ANALYSIS

Plaintiff’s Motion to Remand

In Manguno v. Prudential Property and Casualty Insurance Company, 276 F.3d 720, 723 (5th Cir.2002), the court of *880 appeals reiterated the standards governing removal. Specifically, the court explained:

A party may remove an action from state court to federal court if the action is one over which the federal court possesses subject matter jurisdiction. See 28 U.S.C. § 1441(a). The removing party bears the burden of showing that federal jurisdiction exists and that removal was proper. (Citations omitted.) To determine whether jurisdiction is present for removal, we consider the claims in the state court petition as they existed at the time of removal. (Citation omitted.) Any ambiguities are construed against removal because the removal statute should be strictly construed in favor of remand. (Citation omitted.)

In the case here for consideration, Defendants assert this Court possesses subject matter jurisdiction pursuant to 28 U.S.C. § 1382(a), which provision requires complete diversity of citizenship of the named parties and an amount in controversy in excess of $75,000, exclusive of interest and costs.

Diversity of Citizenship

The parties do not contest the fact that complete diversity of citizenship existed at the time the Original Petition was filed. In his Motion to Remand, however, Plaintiff asserts that Louisiana State University Health Sciences Center, the defendant named in the First Amending Petition, is a citizen of the State of Louisiana whose presence in the litigation destroys diversity and divests this Court of subject matter jurisdiction. In their Notice of Removal, Defendants do not dispute LSUHSC’s Louisiana citizenship. Rather, they argue complete diversity continues on the bases that Plaintiffs First Amending Petition has not yet been properly filed (because Plaintiff did not procure leave of court to file it in state court), and/or that the addition of LSUHSC as a defendant is premature.

Because this Court finds subject matter jurisdiction is lacking for other reasons, discussed in detail below, the diversity of citizenship issues will not be resolved in this forum.

Timeliness of Removal

28 U.S.C. § 1446 outlines the time periods governing removal of actions and provides, in pertinent part:

The notice of removal of a civil action ... shall be filed within thirty days after the receipt by the defendant, through service or otherwise, of a copy of the initial pleading setting forth the claim for relief upon which such action or proceeding is based ....
If the case stated by the initial pleading is not removable, a notice of removal may be filed within thirty days after receipt by the defendant, through service or otherwise, of a copy of an amended pleading, motion, order or other paper from which it may first be ascertained that the case is one which is or has become removable.... (Emphasis added.)

In the initial Petition, Plaintiff sets forth the following claimed damages:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Marcel v. Pool Co.
5 F.3d 81 (Fifth Circuit, 1993)
De Aguilar v. Boeing Co.
47 F.3d 1404 (Fifth Circuit, 1995)
Luckett v. Delta Air Lines, Inc
171 F.3d 295 (Fifth Circuit, 1999)
Simon v. Wal-Mart Stores, Inc.
193 F.3d 848 (Fifth Circuit, 1999)
Gebbia v. Wal-Mart Stores, Inc.
233 F.3d 880 (Fifth Circuit, 2000)
Manguno v. Prudential Property & Casualty Insurance
276 F.3d 720 (Fifth Circuit, 2002)
Bosky v. Kroger Texas, LP
288 F.3d 208 (Fifth Circuit, 2002)
Adam Frederick Chapman v. Powermatic, Inc.
969 F.2d 160 (Fifth Circuit, 1992)
Hydro-Action, Inc. v. James
233 F. Supp. 2d 836 (E.D. Texas, 2002)
Evett v. Consolidated Freightways Corp.
110 F. Supp. 2d 510 (E.D. Texas, 2000)
Century Assets Corp. v. Solow
88 F. Supp. 2d 659 (E.D. Texas, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
281 F. Supp. 2d 878, 2003 U.S. Dist. LEXIS 15919, 2003 WL 22119188, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wise-v-bayer-lawd-2003.